Energy Partitioning in Multicomponent Nanoscintillators for Enhanced Localized Radiotherapy.


Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
24 May 2023
Historique:
medline: 25 5 2023
pubmed: 12 5 2023
entrez: 12 5 2023
Statut: ppublish

Résumé

Multicomponent nanomaterials consisting of dense scintillating particles functionalized by or embedding optically active conjugated photosensitizers (PSs) for cytotoxic reactive oxygen species (ROS) have been proposed in the last decade as coadjuvant agents for radiotherapy of cancer. They have been designed to make scintillation-activated sensitizers for ROS production in an aqueous environment under exposure to ionizing radiations. However, a detailed understanding of the global energy partitioning process occurring during the scintillation is still missing, in particular regarding the role of the non-radiative energy transfer between the nanoscintillator and the conjugated moieties which is usually considered crucial for the activation of PSs and therefore pivotal to enhance the therapeutic effect. We investigate this mechanism in a series of PS-functionalized scintillating nanotubes where the non-radiative energy transfer yield has been tuned by control of the intermolecular distance between the nanotube and the conjugated system. The obtained results indicate that non-radiative energy transfer has a negligible effect on the ROS sensitization efficiency, thus opening the way to the development of different architectures for breakthrough radiotherapy coadjutants to be tested in clinics.

Identifiants

pubmed: 37172016
doi: 10.1021/acsami.3c00853
pmc: PMC10214376
doi:

Substances chimiques

Reactive Oxygen Species 0
Photosensitizing Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24693-24700

Références

Angew Chem Int Ed Engl. 2017 Sep 25;56(40):12102-12106
pubmed: 28804945
J Am Chem Soc. 2009 May 27;131(20):6920-1
pubmed: 19405531
Nanoscale. 2015 Mar 19;7(13):5744-51
pubmed: 25746211
J Nucl Med. 2016 Nov;57(11):1661-1666
pubmed: 27688469
Drug Discov Today. 2018 Oct;23(10):1791-1800
pubmed: 29803933
Chemistry. 2004 Jun 21;10(12):3043-9
pubmed: 15214088
Nano Lett. 2015 Apr 8;15(4):2249-56
pubmed: 25756781
Oncotarget. 2019 Apr 5;10(27):2625-2643
pubmed: 31080554
Chem Rev. 2015 Oct 14;115(19):10725-815
pubmed: 26151155
Theranostics. 2020 Jan 1;10(3):1296-1318
pubmed: 31938066
ACS Nano. 2022 Dec 27;16(12):19691-19721
pubmed: 36378555
ACS Nano. 2013 Jun 25;7(6):5320-9
pubmed: 23721576
Nat Rev Clin Oncol. 2022 Dec;19(12):791-803
pubmed: 36303024
Nanoscale Adv. 2021 Dec 30;4(3):680-696
pubmed: 36131822
Chem Soc Rev. 2019 Jun 4;48(11):3073-3101
pubmed: 31106315
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e549-55
pubmed: 22763031
Int J Mol Sci. 2022 Aug 05;23(15):
pubmed: 35955867
Nat Commun. 2020 May 8;11(1):2298
pubmed: 32385233
Nat Rev Cancer. 2003 May;3(5):380-7
pubmed: 12724736
ACS Appl Mater Interfaces. 2021 Mar 24;13(11):12997-13008
pubmed: 33719410
Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16823-16828
pubmed: 31371494
ACS Nano. 2019 Sep 24;13(9):10419-10433
pubmed: 31430127
Pharmaceutics. 2019 Feb 26;11(3):
pubmed: 30813646
Nanomedicine. 2016 Aug;12(6):1703-24
pubmed: 27033834
Int J Nanomedicine. 2019 Jun 07;14:4247-4259
pubmed: 31239678
Adv Sci (Weinh). 2020 Sep 07;7(20):2001675
pubmed: 33101867
J Phys Chem B. 2013 Nov 14;117(45):13985-92
pubmed: 24111566
Phys Med Biol. 2014 Mar 21;59(6):R183-231
pubmed: 24584183
Nanomedicine. 2016 Aug;12(6):1663-701
pubmed: 27013135
Adv Mater. 2019 Mar;31(12):e1806381
pubmed: 30698854
Nat Biomed Eng. 2018 Aug;2(8):600-610
pubmed: 31015630
CA Cancer J Clin. 2011 Jul-Aug;61(4):250-81
pubmed: 21617154
Radiother Oncol. 2020 Aug;149:158-167
pubmed: 32416282
Biomater Sci. 2018 May 29;6(6):1592-1603
pubmed: 29725684
J Nanosci Nanotechnol. 2006 Apr;6(4):1159-66
pubmed: 16736782

Auteurs

Valeria Secchi (V)

Dipartimento di Scienza Dei Materiali, Università Degli Studi Milano-Bicocca, 20125 Milano, Italy.
NANOMIB, Center for Biomedical Nanomedicine, University of Milano-Bicocca, P.zza Ateneo Nuovo 1, 20126 Milan, Italy.

Francesca Cova (F)

Dipartimento di Scienza Dei Materiali, Università Degli Studi Milano-Bicocca, 20125 Milano, Italy.

Irene Villa (I)

Dipartimento di Scienza Dei Materiali, Università Degli Studi Milano-Bicocca, 20125 Milano, Italy.
FZU─Institute of Physics of the Czech Academy of Sciences, Cukrovarnická 10/112, 16 200 Prague, Czech Republic.

Vladimir Babin (V)

FZU─Institute of Physics of the Czech Academy of Sciences, Cukrovarnická 10/112, 16 200 Prague, Czech Republic.

Martin Nikl (M)

FZU─Institute of Physics of the Czech Academy of Sciences, Cukrovarnická 10/112, 16 200 Prague, Czech Republic.

Marcello Campione (M)

NANOMIB, Center for Biomedical Nanomedicine, University of Milano-Bicocca, P.zza Ateneo Nuovo 1, 20126 Milan, Italy.
Department of Earth and Environmental Sciences, Università Degli Studi Milano-Bicocca, Piazza Della Scienza 4, 20126 Milano, Italy.

Angelo Monguzzi (A)

Dipartimento di Scienza Dei Materiali, Università Degli Studi Milano-Bicocca, 20125 Milano, Italy.
NANOMIB, Center for Biomedical Nanomedicine, University of Milano-Bicocca, P.zza Ateneo Nuovo 1, 20126 Milan, Italy.

Articles similaires

Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Necroptosis as a consequence of photodynamic therapy in tumor cells.

Álvaro Carneiro de Souza, André Luiz Mencalha, Adenilson de Souza da Fonseca et al.
1.00
Photochemotherapy Humans Necroptosis Neoplasms Photosensitizing Agents
Neoplastic Stem Cells Animals Humans Aldehyde Dehydrogenase Tretinoin

Naturally derived 3-aminoquinuclidine salts as new promising therapeutic agents.

Doris Crnčević, Alma Ramić, Andreja Radman Kastelic et al.
1.00
Humans Microbial Sensitivity Tests Anti-Bacterial Agents Biofilms Quinuclidines

Classifications MeSH